バイオ分析試験サービスの世界市場レポート 2025年

バイオ分析試験サービス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.9％で56億1,000万米ドルに成長します。予測期間の成長は、デジタルトランスフォーメーション、ターゲット広告ソリューション、モバイル統合、拡張現実（AR）および仮想現実（VR）、環境持続可能性に起因すると考えられます。予測期間における主な動向としては、クロスチャネルキャンペーン、インタラクティブ広告、モバイル統合、データドリブンターゲティング、プログラマティックバイイングなどが挙げられます。

感染症の発生を抑制するための政府の取り組みが増加していることが、バイオ分析試験サービス市場の成長を大きく促進しています。COVID-19のパンデミックは、これらのサービスに対する需要を高め、世界各国が病気の蔓延と影響を防ぐための取り組みを強化し、資金を増やすよう促しています。例えば、2023年3月、米国を拠点とする公共政策研究機関である議会調査局の報告書によると、アレルギー・感染症（NIAID）に対する米国国立衛生研究所（NIH）からの資金は、2023年に63億2,300万米ドルから65億6,200万米ドルに増加しました。したがって、感染症の発生を管理することを目的とした政府のイニシアチブの高まりは、バイオ分析試験サービス市場を煽っています。

慢性疾患の有病率の高まりは、当面のバイオ分析試験サービス市場の成長を促進すると予測されています。慢性疾患は、3ヶ月以上持続し、時間の経過とともに悪化する可能性のある病気であるため、効果的な診断およびモニタリングツールが必要となります。バイオ分析試験サービスは、慢性疾患に関連する特定のバイオマーカーを同定・測定し、治療範囲内の最適な薬物濃度を確保するための治療薬モニタリングに役立つという重要な役割を担っています。一例として、国立医学図書館は2023年1月に、米国では50歳以上で少なくとも1つの慢性疾患を持つ人の数が99.5％増加し、2050年には1億4,266万人に達すると予測していると報告しています。さらに、世界保健機関（WHO）が2022年9月に発表した「2022年ハイライト」によると、世界全体の死亡者数の74％、年間4100万人が非感染性疾患（NCDs）または慢性疾患によるものです。このような慢性疾患の急増は、バイオ分析試験サービス市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオ分析試験サービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオ分析試験サービス市場：成長率分析
• 世界のバイオ分析試験サービス市場の実績：規模と成長, 2019-2024
• 世界のバイオ分析試験サービス市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオ分析試験サービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオ分析試験サービス市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ADME（吸収、流通、代謝、排泄）
• 吸収研究
• 流通研究
• 代謝研究
• 排泄研究
• 世界のバイオ分析試験サービス市場分子タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小分子
• 巨大分子
• 世界のバイオ分析試験サービス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオ医薬品企業
• 契約開発製造組織
• 契約調査機関
• 世界のバイオ分析試験サービス市場、ADME（吸収、流通、代謝、排泄）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸収研究
• 流通研究
• 代謝研究
• 排泄研究
• 世界のバイオ分析試験サービス市場、薬物動態のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Cmax（最大濃度）
• Tmax（Cmaxに到達するまでの時間）
• AUC（曲線下面積）
• 半減期研究
• 世界のバイオ分析試験サービス市場、薬力学のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 有効性試験
• 安全性試験
• 用量反応関係研究
• 世界のバイオ分析試験サービス市場、生物学的同等性のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生体内生物学的同等性試験
• インビトロ生物学的同等性試験
• 世界のバイオ分析試験サービス市場、バイオアベイラビリティのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 絶対バイオアベイラビリティ研究
• 相対的バイオアベイラビリティ研究

第7章 地域別・国別分析

• 世界のバイオ分析試験サービス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオ分析試験サービス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオ分析試験サービス市場：競合情勢
• バイオ分析試験サービス市場：企業プロファイル
  • CD BioSciences Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings（LabCorp）Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• ICON plc
• PPD Inc.
• SGS SA
• WuXi AppTec
• Syneos Health Inc.
• Sartorius AG
• Charles River Laboratories Inc.
• Intertek Group
• Covance Inc.
• PAREXEL International Corporation
• Element Materials Technology
• ALS Limited
• Medpace Holdings Inc.
• Almac Group
• Pace Analytical Services LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオ分析試験サービス市場2029：新たな機会を提供する国
• バイオ分析試験サービス市場2029：新たな機会を提供するセグメント
• バイオ分析試験サービス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bioanalytical testing services encompass cutting-edge methodologies for quantifying analytes. These services play a pivotal role in identifying and characterizing pharmaceuticals and metabolites within biological fluids such as blood, plasma, serum, urine, or tissue extracts.

Bioanalytical testing services encompass various essential tests, including ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic, pharmacodynamic, bioequivalence, and bioavailability assessments. ADME examines how a chemical undergoes absorption, distribution, metabolism, and excretion within a living organism, crucial for understanding drug processing. It aids in evaluating safety, toxicity, and the viability of drugs, offering precise targets for future research and development endeavors. These testing services analyze both small and large molecules, catering to pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, as well as contract research organizations. They serve as indispensable tools in drug development and assessment, providing vital insights into a compound's behavior within biological systems.

The bioanalytical testing services market research report is one of a series of new reports from The Business Research Company that provides bioanalytical testing services market statistics, including bioanalytical testing services industry global market size, regional shares, competitors with a bioanalytical testing services market share, detailed bioanalytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the bioanalytical testing services industry. This bioanalytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioanalytical testing services market size has grown strongly in recent years. It will grow from $3.45 billion in 2024 to $3.71 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to mobility and transportation changes, environmental considerations, cultural and social trends, competition and industry growth, innovations in design and creativity.

The bioanalytical testing services market size is expected to see rapid growth in the next few years. It will grow to $5.61 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to digital transformation, targeted advertising solutions, mobile integration, augmented reality (AR) and virtual reality (VR), environmental sustainability. Major trends in the forecast period include cross-channel campaigns, interactive advertising, mobile integration, data-driven targeting, programmatic buying.

The increasing government initiatives to control infectious disease outbreaks are significantly driving the growth of the bioanalytical testing services market. The COVID-19 pandemic has heightened demand for these services, prompting countries worldwide to enhance efforts and increase funding to prevent the spread and impact of diseases. For example, in March 2023, a report from the Congressional Research Service, a U.S.-based public policy research institute, indicated that funding from the National Institutes of Health (NIH) for Allergy and Infectious Diseases (NIAID) rose from $6,323 million to $6,562 million in 2023. Therefore, the growing government initiatives aimed at managing infectious disease outbreaks are fueling the bioanalytical testing services market.

The escalating prevalence of chronic diseases is anticipated to drive the growth of the bioanalytical testing services market in the foreseeable future. Chronic diseases, characterized by enduring illness lasting three months or more and with the potential to worsen over time, necessitate effective diagnostic and monitoring tools. Bioanalytical testing services play a crucial role in identifying and measuring specific biomarkers associated with chronic diseases, aiding in therapeutic drug monitoring to ensure optimal drug levels within the therapeutic range. As an example, the National Library of Medicine reported in January 2023 that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Furthermore, according to the World Health Organization's 2022 Highlights in September 2022, 74% of all global deaths, amounting to 41 million annually, result from noncommunicable diseases (NCDs) or chronic diseases. This surge in chronic diseases' prevalence is a key driver propelling the growth of the bioanalytical testing services market.

Major companies within the bioanalytical testing services market are actively pursuing advanced solutions, exemplified by the introduction of technologies such as reverse transcription PCR (RT-PCR) tests, to fortify their market positions. RT-PCR is a laboratory technique involving the conversion of RNA into complementary DNA (cDNA) using the reverse transcriptase enzyme. A case in point is Eurofins Scientific SE, a France-based testing laboratory company, which, in June 2023, launched the NovaType SARS-CoV-2 RT-PCR assay. This clinically validated assay offers a short turnaround time, making it well-suited for the re-testing of millions of positive samples to identify specific virus variants. The NovaType SARS-CoV-2 RT-PCR assay, functioning in real-time, is designed for the qualitative detection of SARS-CoV-2, the virus responsible for COVID-19, and the subsequent identification of specific variants, including B.1.1.7 and B.1.351. This strategic focus on advanced solutions underscores the commitment of major companies to staying at the forefront of technological advancements in the bioanalytical testing services market.

Major companies in the bioanalytical testing services market are concentrating on developing testing facilities to maintain their competitive edge. These facilities are specialized environments designed and equipped to perform various tests on products, materials, systems, or components. For instance, in August 2024, SGS S.A., a Switzerland-based inspection, verification, testing, and certification service provider, launched new specialized bioanalytical testing services at its facility in Hudson, New Hampshire. This initiative aims to enhance support for various stages of drug development, particularly focusing on discovery, pre-clinical, and clinical trials from phases 1 to 3. The newly introduced services include method transfer, validation, pharmacokinetics (PK) bioanalysis, immunogenicity testing, and a variety of bioassays.

In February 2022, Eurofins Scientific, a France-based laboratory service company, announced the acquisition of Genetic Testing Service JSC for an undisclosed amount. This strategic move is expected to facilitate Eurofins' expansion in the clinical genetic testing market and complement its global network of clinical diagnostics laboratories. Genetic Testing Service JSC, based in Vietnam, is a company specializing in genetic testing services, including specialized DNA testing, genealogical DNA tests, and testing for conditions such as cancer and COVID-19.

Major companies operating in the bioanalytical testing services market include CD BioSciences, Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, ICON plc, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., Sartorius AG, Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Element Materials Technology, ALS Limited, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc., Cinven Ltd. (LGC Limited), Toxikon Inc., Absorption Systems LLC, Lotus Labs Pvt. Ltd., Bioneeds India Private Limited, Vipragen Biosciences Pvt. Ltd., Source BioScience

North America was the largest region in the bioanalytical testing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioanalytical testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioanalytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioanalytical testing services market includes revenues earned by entities by providing services such as method development, high throughput sample analysis, method validation, and pharmacokinetic and toxicokinetic support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioanalytical Testing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioanalytical testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioanalytical testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioanalytical testing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: ADME (Absorption, Distribution, Metabolism, And Excretion); Pharmacokinetic; Pharmacodynamic; Bioequivalence; Bioavailability
• 2) By Molecule Type: Small Molecules; Large Molecules
• 3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Contract Research Organizations
• Subsegments:
• 1) By ADME (Absorption, Distribution, Metabolism, and Excretion): Absorption Studies; Distribution Studies; Metabolism Studies; Excretion Studies
• 2) By Pharmacokinetic: Cmax (Maximum Concentration); Tmax (Time To Reach Cmax); AUC (Area Under the Curve); Half-Life Studies
• 3) By Pharmacodynamic: Efficacy Testing; Safety Testing; Dose-Response Relationship Studies
• 4) By Bioequivalence: In Vivo Bioequivalence Studies; In Vitro Bioequivalence Studies
• 5) By Bioavailability: Absolute Bioavailability Studies; Relative Bioavailability Studies
• Companies Mentioned: CD BioSciences; Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioanalytical Testing Services Market Characteristics

3. Bioanalytical Testing Services Market Trends And Strategies

4. Bioanalytical Testing Services Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bioanalytical Testing Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioanalytical Testing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioanalytical Testing Services Market Growth Rate Analysis
• 5.4. Global Bioanalytical Testing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioanalytical Testing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioanalytical Testing Services Total Addressable Market (TAM)

6. Bioanalytical Testing Services Market Segmentation

• 6.1. Global Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ADME (Absorption, Distribution, Metabolism, And Excretion)
• Absorption Studies
• Distribution Studies
• Metabolism Studies
• Excretion Studies
• 6.2. Global Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecules
• Large Molecules
• 6.3. Global Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biopharmaceutical Companies
• Contract Development And Manufacturing Organizations
• Contract Research Organizations
• 6.4. Global Bioanalytical Testing Services Market, Sub-Segmentation Of ADME (Absorption, Distribution, Metabolism, and Excretion), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Absorption Studies
• Distribution Studies
• Metabolism Studies
• Excretion Studies
• 6.5. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Pharmacokinetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cmax (Maximum Concentration)
• Tmax (Time To Reach Cmax)
• AUC (Area Under the Curve)
• Half-Life Studies
• 6.6. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Pharmacodynamic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Efficacy Testing
• Safety Testing
• Dose-Response Relationship Studies
• 6.7. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Bioequivalence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vivo Bioequivalence Studies
• In Vitro Bioequivalence Studies
• 6.8. Global Bioanalytical Testing Services Market, Sub-Segmentation Of Bioavailability, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Absolute Bioavailability Studies
• Relative Bioavailability Studies

7. Bioanalytical Testing Services Market Regional And Country Analysis

• 7.1. Global Bioanalytical Testing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioanalytical Testing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioanalytical Testing Services Market

• 8.1. Asia-Pacific Bioanalytical Testing Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioanalytical Testing Services Market

• 9.1. China Bioanalytical Testing Services Market Overview
• 9.2. China Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioanalytical Testing Services Market

• 10.1. India Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioanalytical Testing Services Market

• 11.1. Japan Bioanalytical Testing Services Market Overview
• 11.2. Japan Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioanalytical Testing Services Market

• 12.1. Australia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioanalytical Testing Services Market

• 13.1. Indonesia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioanalytical Testing Services Market

• 14.1. South Korea Bioanalytical Testing Services Market Overview
• 14.2. South Korea Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioanalytical Testing Services Market

• 15.1. Western Europe Bioanalytical Testing Services Market Overview
• 15.2. Western Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioanalytical Testing Services Market

• 16.1. UK Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioanalytical Testing Services Market

• 17.1. Germany Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioanalytical Testing Services Market

• 18.1. France Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioanalytical Testing Services Market

• 19.1. Italy Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioanalytical Testing Services Market

• 20.1. Spain Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioanalytical Testing Services Market

• 21.1. Eastern Europe Bioanalytical Testing Services Market Overview
• 21.2. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioanalytical Testing Services Market

• 22.1. Russia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioanalytical Testing Services Market

• 23.1. North America Bioanalytical Testing Services Market Overview
• 23.2. North America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioanalytical Testing Services Market

• 24.1. USA Bioanalytical Testing Services Market Overview
• 24.2. USA Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioanalytical Testing Services Market

• 25.1. Canada Bioanalytical Testing Services Market Overview
• 25.2. Canada Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioanalytical Testing Services Market

• 26.1. South America Bioanalytical Testing Services Market Overview
• 26.2. South America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioanalytical Testing Services Market

• 27.1. Brazil Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioanalytical Testing Services Market

• 28.1. Middle East Bioanalytical Testing Services Market Overview
• 28.2. Middle East Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioanalytical Testing Services Market

• 29.1. Africa Bioanalytical Testing Services Market Overview
• 29.2. Africa Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioanalytical Testing Services Market Competitive Landscape And Company Profiles

• 30.1. Bioanalytical Testing Services Market Competitive Landscape
• 30.2. Bioanalytical Testing Services Market Company Profiles
  • 30.2.1. CD BioSciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Bioanalytical Testing Services Market Other Major And Innovative Companies

• 31.1. ICON plc
• 31.2. PPD Inc.
• 31.3. SGS SA
• 31.4. WuXi AppTec
• 31.5. Syneos Health Inc.
• 31.6. Sartorius AG
• 31.7. Charles River Laboratories Inc.
• 31.8. Intertek Group
• 31.9. Covance Inc.
• 31.10. PAREXEL International Corporation
• 31.11. Element Materials Technology
• 31.12. ALS Limited
• 31.13. Medpace Holdings Inc.
• 31.14. Almac Group
• 31.15. Pace Analytical Services LLC

32. Global Bioanalytical Testing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioanalytical Testing Services Market

34. Recent Developments In The Bioanalytical Testing Services Market

35. Bioanalytical Testing Services Market High Potential Countries, Segments and Strategies

• 35.1 Bioanalytical Testing Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioanalytical Testing Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioanalytical Testing Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer